Connect with us

NEWS

Congo Ebola Cases Hit 10,920 as Contact Lists Fail

Congo’s Bundibugyo Ebola outbreak has 10,920 confirmed cases, most still off contact lists, with no licensed vaccine and trial results due in 2027.

Published

on

Congo has recorded 10,920 confirmed Bundibugyo Ebola cases and 5,323 deaths, European health officials said, with most new infections still arriving from people never listed as contacts. The Democratic Republic of the Congo’s 17th Ebola outbreak, declared on 15 May 2026, is now the largest in the country’s history and the second-largest ever recorded. About 80 percent of recorded cases still come from outside monitored contacts, far from the 95 percent share Africa CDC says is needed before an outbreak can be called largely under control.

Most New Cases Still Arrive From Outside Contact Lists

The case total is a count of people the labs have already seen. It is not a map of who will be next. Africa CDC has said that, for officials to treat an Ebola outbreak as largely in hand, at least 95 percent of recorded cases should come from known contacts. Congo is nowhere near that mark.

The World Health Organization, in a 6 November notice using data through 3 November, said the daily average share of identified contacts actually seen over 14 days was 86 percent, below a 95 percent operational target. That figure tracks people already on a list. The 80 percent share of new cases coming from outside those lists is a different failure: whole chains that were never written down.

Of 512 deaths logged from 21 October through 3 November, 335 happened in the community and 177 in treatment centres. WHO called that a high proportion of deaths in communities, especially among young children, and a sign that people still reach care late, or not at all. At least half of all recorded deaths have been among people who were never admitted, responders have said.

THE SURVEILLANCE GAP

  • Unknown chains: About 80 percent of recorded cases still come from people who were not being monitored as contacts.
  • Follow-up of known contacts: 86 percent of identified contacts were seen each day over 14 days, short of the 95 percent target.
  • Community deaths: 335 of 512 deaths from 21 October through 3 November occurred outside treatment centres.
  • Active belt: 51 of 67 affected health zones reported at least one new case in the 21 days to 3 November.

In that same 21-day window, WHO counted 1,463 new confirmed cases. Ituri supplied 710 of them and North Kivu 640. Tshopo, Haut-Uélé and Nord-Ubangi added the rest. Bas-Uélé, South Kivu and Sud-Ubangi reported none in those three weeks, which is not the same as a finished outbreak.

Ituri Still Carries Most of Congo’s Confirmed Cases

European health officials, using data through 7 November, put Congo at 10,920 confirmed cases and 5,323 deaths, with 2,940 people recovered and 1,010 patients in isolation. The crude case fatality ratio is 48.7 percent. Eight provinces have recorded confirmed infections. Ituri still holds most of them.

CONFIRMED CASES BY PROVINCE

Province Confirmed cases Deaths
Ituri 7,614 3,594
North Kivu 2,697 1,478
Haut-Uélé 486 213
Tshopo 96 31
Four other provinces 27 7
DRC total 10,920 5,323

North Kivu’s fatality ratio is 54.8 percent, the highest among the large provinces. WHO said Beni, Bunia and Mandima logged the most cases and deaths in the 21 days to 3 November, and that North Kivu had the most new cases in the last seven days of that window, 232. Yakoma, in Nord-Ubangi on the Central African Republic border, is the newest named health zone.

The U.S. Centers for Disease Control and Prevention said this outbreak reached 1,000 confirmed cases within 40 days of response activation. The 2018 North Kivu outbreak took about 235 days to cross that line. That earlier epidemic, Congo’s previous worst, finished with 3,470 cases and 2,287 deaths across 29 health zones after nearly two years. This one has already passed both totals, in 67 zones, with no licensed Bundibugyo vaccine in the bag.

Why Bundibugyo Still Has No Licensed Vaccine

Bundibugyo virus caused outbreaks in Uganda in 2007 and in Congo in 2012. Fatality ratios then were about 30 percent and 50 percent. Licensed Ebola tools built after West Africa and after North Kivu target Zaire virus. Ervebo, the rVSV shot used in those responses, is not approved for Bundibugyo, and WHO has judged the cross-protection evidence too thin to send it out as a public campaign.

Virologist Marion Koopmans wrote that Bundibugyo outbreaks had been seen before, yet vaccine work went to Zaire and Sudan. The cost of that choice is now measured in eastern Congo. Africa CDC Director-General Jean Kaseya, in a Nairobi interview, put the gap in plain words: the response does not have vaccines and medicines, does not have enough trained people, and is not getting enough money from African governments.

What exists is research layered onto a shooting war. The Tumaini Phase 2/3 platform trial enrolled its first participants in Bunia on 23 October, using ring vaccination around confirmed cases. Ervebo is the first candidate in that trial, tested for any cross-effect. On 4 November, WHO expert groups recommended that two new candidate vaccines to join Tumaini after national approvals: ChAdOx1 BDBV, from the University of Oxford and the Serum Institute of India, and Moderna’s mRNA-1469. WHO said this will be the first time shots built for Bundibugyo are tested during an outbreak of that virus. Initial results are expected in early 2027.

The Coalition for Epidemic Preparedness Innovations said in June that it would fast-tracks three Bundibugyo vaccine candidates, including an IAVI rVSV construct that was then still months from human efficacy tests. Africa CDC said that as of 3 November, 20,000 frontline and health workers had been vaccinated, a Zaire-tool stopgap, not a Bundibugyo licence. Treatment studies are running in parallel: PARTNERS had enrolled 842 people by 3 November toward a 1,500 to 2,000 target, testing MBP134 and remdesivir, with maftivimab due to be added; EBO-PEP had enrolled 765 high-risk contacts, of a 1,000 target, on Gilead’s pill obeldesivir.

Vaccines alone will not end this outbreak, but they could become a powerful new tool for bringing it under control.

Tedros Adhanom Ghebreyesus, WHO Director-General, 4 November 2026 statement

Incubation runs from two to 21 days. Infected people are not contagious until symptoms start, which often look like malaria at first. Without a licensed Bundibugyo shot, control still rests on finding the sick early, isolating them, tracing contacts, burying the dead safely, and persuading families who have learned to fear the response itself.

A Nurse Was Killed on an Alert Call

On 24 October in Bafwasende, Tshopo province, a nurse answering an Ebola alert was killed and a second health worker was badly hurt. Julien Harneis, the senior United Nations Ebola coordinator, called the killing a loss to the response and a greater loss to patients, and asked for a full investigation. Dr Marcel Likolo, chief medical officer of the Bafwasende health district, said local youths accused the pair of trying to infect people with tablets. The treatment centre where the attack happened was then shut.

Other staff in the town sheltered at the general hospital under police guard, too afraid to sleep at home. The pattern is old. During the 2018 to 2020 North Kivu outbreak, WHO counted 420 attacks on health facilities, with 11 people killed and 86 injured. This wave has the same mistrust, now without the Zaire vaccine that eventually helped that earlier fight.

Pay is part of the break. In Nia Nia health zone in Ituri, surveillance and community officers walked off over unpaid bonuses owed since late August, a complaint responders describe as common. Treatment centres in some zones are full. Health workers have struck over delayed wages while still being asked to enter houses that do not want them.

Some people still don’t seem to understand the seriousness of the situation even though they are directly exposed to the risk. Ebola disease is extremely dangerous and can be deadly.

Sephora Bgosi, Ebola burial team, Ituri province

Bgosi’s work is the part of the response families see last. Safe burial teams ask relatives to hand over bodies. In many zones, that request is refused. Vehicles are short. Rumours move faster than sample results. A viral clip of staff in full protective gear dancing as the last two patients left a centre in Mongbwalu, Ituri, gave one town a night of relief. Tedros said of that video that the outbreak was far from over, and that every life saved was worth celebrating.

Pregnant Women Began Avoiding Hospitals After May

The virus is not the only killer on the ledger. After the outbreak was declared, more pregnant women stayed away from hospitals for fear of infection and isolation, and maternal deaths doubled in some provinces. Childhood vaccination paused in places where millions of children were already out of school. Cholera, already in the country, lost staff and attention. Families already living with conflict lost markets, wages and the thin routine of clinic days.

WHAT THE OUTBREAK HAS PUSHED ASIDE

  • Maternity wards: Pregnant women have avoided hospitals, and maternal deaths have doubled in some provinces since May.
  • Childhood shots: Routine immunisation has been interrupted in affected zones.
  • Other epidemics: Cholera response has been stretched as teams and funds shifted to Ebola.
  • Classrooms: Schooling has been disrupted for children in a country where millions were already out of class.

The International Organization for Migration said on 10 November that its surveillance had flagged 71 alerts on displacement routes since the outbreak began, and that a $59.8 million funding gap now threatens that work. Kaseya named the same holes from another angle: too few people, no Bundibugyo medicines, weak community trust, and paper records that cannot keep up with a moving epidemic. Africa CDC has been building country offices and laboratory networks under a longer health-security plan. Those projects do not staff a burial team in Bafwasende tonight.

Kenya Held One Cluster While Congo Stayed Hot

The virus has left Congo. It has not run free in the same way. Cases have been recorded in five countries since 15 May: Congo, Uganda, France, Kenya and Nigeria. Uganda’s outbreak, 20 confirmed cases and one probable case with three deaths in all, was declared over after the last confirmation on 21 June. France recorded one case and has had no active infections since August. Two later medical evacuations, a Nigerian patient to Geneva on 26 October and a health worker from Congo to London on 5 November, were transfers of known patients, not new national outbreaks.

Kenya has nine confirmed cases and two deaths, all in Nairobi and all tied to one imported index patient who travelled from Congo through Uganda and died in isolation. WHO said the eight later cases were four family members and four health workers, and that every one of them was already in quarantine when symptoms began. Five patients were discharged on 3 November. Two remained in care. Of 135 contacts, follow-up for the last 52 was due to end on 11 November. Kenya had screened 760,415 travellers at designated posts by 5 November. Nigeria reported one imported case in Abuja on 20 October and identified 62 contacts.

That is what a complete contact list looks like. Congo’s list is the hole in the middle of the 10,920.

FROM DECLARATION TO THE 10,920 MARK

  1. 15 May 2026: Congo and Uganda declare Bundibugyo virus disease outbreaks.
  2. 17 May 2026: WHO determines the event is a Public Health Emergency of International Concern.
  3. 21 June 2026: Uganda records its last confirmed case; that outbreak is later closed.
  4. 6 October 2026: Kenya confirms an imported case in Nairobi after travel from Congo via Uganda.
  5. 20 October 2026: Nigeria confirms one imported case in Abuja.
  6. 23 October 2026: Tumaini vaccine trial enrols first participants in Bunia.
  7. 24 October 2026: A nurse is killed answering an Ebola alert in Bafwasende.
  8. 4 November 2026: WHO advisers recommend adding two Bundibugyo-specific vaccine candidates to Tumaini.
  9. 7 November 2026: European health officials report 10,920 confirmed cases and 5,323 deaths in Congo.

African health ministers, meeting virtually on 28 October, agreed to keep borders open and to watch them more closely, rather than shut them. Kaseya told them that no country is safe if it tries to stand alone. WHO still advises against travel and trade bans. The science due in early 2027 will not staff the 51 zones that were still lighting up in early November, and it will not put unpaid burial teams back on the road. Until most new cases come from names already on a page, the count will keep rising in places the lists do not include.

Disclaimer: This article is news reporting on an ongoing outbreak and related vaccine and treatment research. It is informational only and is not medical advice, a diagnosis, or a guide to vaccination, travel, or clinical care. Readers who have symptoms, possible exposure, or questions about shots or treatment should contact a qualified physician or local public health authority. Case counts, death totals, trial status and travel guidance reflect the official sources cited and can change as ministries and agencies issue new figures.

Harry is the editor of THE iBULLETIN, an independent publication he owns and runs. He has been in journalism for ten years, first reporting and later editing, and much of what the site covers now begins in its inbox. Reader mail is read in full, every message of it. A tip is treated as a lead to be verified, not a story to be printed, and a challenge to a published fact is checked against the original filing, statement or transcript within the day, with the article corrected under a public policy if the reader is right. Questions that several readers ask become articles. That exchange feeds coverage of news, business and technology, of science and sports, and of entertainment, lifestyle, travel, auto and gaming, written for readers spread across many countries rather than one. Harry works from primary sources and checks each number himself before publication, and he would rather run a shorter story than an unconfirmed one. The address for all of it, tips, corrections and questions alike, is support@theibulletin.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending